All Stories

  1. You wait ages, and then two arrive at once: reporting guidelines should not be like buses
  2. Low‐dose isotretinoin for difficult‐to‐treat rosacea: Enough evidence to be convinced—What's next?
  3. Developing reporting checklist items from systematic review findings: a roadmap and lessons to be learned from ACCORD
  4. Tuning up the chords of consensus research with the ACcurate COnsensus Reporting Document (ACCORD)
  5. ACcurate COnsensus Reporting Document (ACCORD) explanation and elaboration: Guidance and examples to support reporting consensus methods
  6. Delayed Onset Type I Allergic Reaction Following Black Tattoo Removal Using Picosecond Laser
  7. Global Guidelines in Dermatology Mapping Project (GUIDEMAP)—A systematic review of the methodological quality of contact dermatitis clinical practice guidelines
  8. Rosacea
  9. ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi
  10. Frequency and clinical relevance of contact allergy in dental patients
  11. The future is now: the Global Atopic Dermatitis Atlas (GADA)
  12. Guideline-based intervention improves the quality of antibiotic allergy registration in a hospital setting
  13. Existing guidance on reporting of consensus methodology: a systematic review to inform ACCORD guideline development
  14. ACCORD guideline for reporting consensus-based methods in biomedical research and clinical practice: a study protocol
  15. Network meta‐analysis: methodological points for readers, authors and reviewers
  16. Global Guidelines in Dermatology Mapping Project ( GUIDEMAP ), a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased, trustworthy and evidence based ( CUTE
  17. Contact allergy to a shellac‐containing mouthguard
  18. Gustatory Hyperhidrosis
  19. Rosacea treatments: Current standards and additional options
  20. Harmonizing Measurement of Satisfaction With Acne Scar Treatments: Can We All Sing the Same Tune?
  21. Rosacea: New Concepts in Classification and Treatment
  22. Identifying and appraising patient‐reported outcome measures on treatment satisfaction in acne: a systematic review*
  23. Publication of national dermatology guidelines as a Research Letter in the BJD : can less ever be enough?
  24. Rosacea treatment guideline for The Netherlands
  25. Rosacea treatment guideline for the Netherlands
  26. Consistency of Recommendations for Evaluation and Management of Hypertension
  27. Recommendations for rosacea diagnosis, classification and management: update from the global ROS acea CO nsensus 2019 panel
  28. Common methodological pitfalls and new developments in systematic review meta‐analyses
  29. Antibiotic use for irreversible pulpitis
  30. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments
  31. Why does the BJD require registration of systematic reviews and meta-analyses?
  32. Effects of low-carbohydrate- compared with low-fat-diet interventions on metabolic control in people with type 2 diabetes: a systematic review including GRADE assessments
  33. Is there randomized controlled trial evidence to support the use of interventions for preventing occupational irritant hand dermatitis (OIHD)?
  34. A breathtaking DRESS due to amoxicillin-clavulanate presenting as polymorphic eruption of the pregnancy
  35. Light on fumaric acid esters therapy for psoriasis
  36. Palladium-induced granulomas analysed with inductively coupled plasma mass spectrometry
  37. AGREE II assessments of recent acne treatment guidelines: how well do they reveal trustworthiness as defined by the U.S. Institute of Medicine criteria?
  38. Rosacea
  39. Laser treatment of congenital melanocytic nevi: a systematic review
  40. Emollients and moisturizers for eczema: abridged Cochrane systematic review including GRADE assessments
  41. Introducing the new Evidence-Based Dermatology section
  42. Systematic reviews: let's keep them trustworthy
  43. News and Notices
  44. Performance and Tolerability of the Moisturizers Cetaphil® and Excipial® in Atopic Dermatitis: What is the Evidence Based on Randomized Trials?
  45. Interventions for Female Pattern Hair Loss
  46. Emollients and moisturisers for eczema
  47. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
  48. Rosacea treatment update: recommendations from the global ROS acea CO nsensus ( ROSCO ) panel
  49. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROS acea CO nsensus ( ROSCO ) panel
  50. Epidermal growth factor receptor inhibitor-associated rash prevented by oral tetracyclines
  51. Shared decision making and patient decision aids in dermatology
  52. Moose on the loose: checklist for meta-analyses of observational studies
  53. Moose on the loose
  54. Which antibiotic is the most effective  in people with cellulitis and erysipelas?
  55. Prevalence and odds of Staphylococcus aureuscarriage in atopic dermatitis: a systematic review and meta-analysis
  56. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review includingGRADEassessments
  57. 10.1007/s10096-016-2647-3
  58. 10.1016/j.jid.2016.03.003
  59. A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea
  60. RAPADAPTE for rapid guideline development: high-quality clinical guidelines can be rapidly developed with limited resources
  61. Emollients and moisturisers for eczema
  62. Antibiotic use for irreversible pulpitis
  63. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease
  64. Interventions for Rosacea
  65. Interventions for Hirsutism
  66. Day care versus in-patient surgery for age-related cataract
  67. Diphencyprone treatment in patients with alopecia areata
  68. Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments
  69. Paleo systematic review
  70. Limitations in conduct and reporting of cochrane reviews rarely inhibit the determination of the validity of evidence for clinical decision-making
  71. Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment
  72. Interventions for rosacea
  73. Interventions for hirsutism (excluding laser and photoepilation therapy alone)
  74. Interventions for skin reactions associated with targeted anticancer treatments
  75. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review
  76. Penicillin to prevent recurrent leg cellulitis: a critical appraisal
  77. Alpine climate treatment of atopic dermatitis: a systematic review
  78. Topical antifungal treatments for tinea cruris and tinea corporis
  79. Low-Molecular-Weight Heparins for Managing Vasoocclusive Crises in People With Sickle Cell Disease: A Summary of a Cochrane Systematic Review
  80. Selenium supplementation for Hashimoto’s thyroiditis
  81. Contact urticaria from beer
  82. Contact allergy to Tinosorb® M: recommendations for diagnostic improvement
  83. No high level evidence to support the use of oral H1 antihistamines as monotherapy for eczema: a summary of a Cochrane systematic review
  84. Antibiotic use for irreversible pulpitis
  85. Selenium Supplementation for Hashimoto's Thyroiditis: Summary of a Cochrane Systematic Review
  86. Efficacy of Topical Antifungal Agents in the Treatment of Dermatophytosis: An Incomplete Meta-Analysis
  87. Oral rinses, mouthwashes and sprays for improving recovery following tonsillectomy
  88. Botulinum toxin for masseter hypertrophy
  89. Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review
  90. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease
  91. Selenium supplementation for Hashimoto's thyroiditis
  92. Oral H1 antihistamines as monotherapy for eczema
  93. Interventions for hirsutism excluding laser and photoepilation therapy
  94. 'Liberation procedure' for treatment of venous stenoses (CCSVI) in the brain of MS sufferers
  95. Selenium supplementation for Hashimoto's thyroiditis
  96. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease
  97. Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review
  98. Lack of ‘appropriately assessed’ patient-reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea
  99. Interventions for female pattern hair loss
  100. Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients
  101. Interventions for female pattern hair loss
  102. Beta2-adrenoceptor agonists for dysmenorrhoea
  103. Histamine H2-receptor antagonists for urticaria
  104. Effective and evidence‐based management strategies for rosacea: summary of a Cochrane systematic review
  105. Day care versus in-patient surgery for age-related cataract
  106. Interventions for skin reactions associated with targeted anticancer treatments
  107. Interventions for rosacea
  108. Anaphylaxis after consuming soy products in patients with birch pollinosis
  109. An unusual case of contact dermatitis to procaine
  110. Cutaneous Allergy Testing in Patients Suspected of an Allergic Reaction to Eye Medication
  111. Moet een recidiverende furunkel op de neus direct met antibiotica worden behandeld?
  112. Relevance of Positive Patch-Test Reactions to Fragrance Mix
  113. Systematic review of rosacea treatments
  114. Heeft de Diane-pil een gunstige invloed op rosacea?
  115. Kan ‘chirurgisch staal’ ook een allergie verooorzaken?
  116. Is het zinvol om bij toepassing van dermatologica bij eczeem te kiezen voor een wolvet-vrij vehiculum?
  117. Betekent een allergie voor acetylsalicylzuur ook een allergie voor andere NSAID’s?
  118. Anaphylaxis to patent blue during sentinel lymph node identification
  119. Interventions for rosacea
  120. Nieuwe topicale immunomodulatoren voor de behandeling van atopisch eczeem
  121. Immediate type hypersensitivity after injection of nadroparin (Fraxiparin)
  122. Evidence-Based Dermatology
  123. Interventions for rosacea
  124. Diffuse neurofibroma on the lower back
  125. Computer-related skin diseases
  126. Aleukaemic leukaemia cutis in a patient with acute T-cell lymphoblastic leukaemia
  127. Recalcitrant atopic dermatitis due to allergy to Compositae
  128. Psychosocial Impact of Acne vulgaris
  129. Interventions for acne rosacea
  130. Basal cell carcinoma on the dorsum of the hand: report of 11 cases
  131. Carcinoma of the lip in kidney transplant recipients
  132. Treatment of recurrent squamous cell carcinoma of the hand in immunonosuppressed patients
  133. Resurfacing the back of the hand as treatment and prevention of multiple skin cancers in kidney transplant recipients
  134. A randomized clinical trial to compare two different approaches in women with chronic pelvic pain